'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
Saved in:
| Title: | 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab. |
|---|---|
| Authors: | Vissing J; Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark. john.vissing@regionh.dk., Jacob S; Queen Elizabeth Neuroscience Centre and Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham, B15 2WB, UK., Fujita KP; Alnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, MA, 02142, USA.; Formerly Alexion Pharmaceuticals, 121 Seaport Boulevard, Boston, MA, 02210, USA., O'Brien F; Alexion Pharmaceuticals, 121 Seaport Boulevard, Boston, MA, 02210, USA., Howard JF; Department of Neurology, University of North Carolina, 170 Manning Drive, Chapel Hill, NC, 27599-7025, USA. |
| Corporate Authors: | REGAIN study group |
| Source: | Journal of neurology [J Neurol] 2020 Jul; Vol. 267 (7), pp. 1991-2001. Date of Electronic Publication: 2020 Mar 18. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
